GlassScriptPhysician profile
Luke Wren
NPI 1922637537
$600.07
in general payments reported to CMS, 2019-2025
16 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $69.37 · 2024: $293 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $134.04 | 2023-2025 | Qulipta |
| Novartis Pharmaceuticals Corporation | $65.22 | 2024-2025 | |
| Exact Sciences Corporation | $61.40 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $59.10 | 2024-2025 | Airsupra, Breztri |
| Phathom Pharmaceuticals, INC. | $53.01 | 2024-2025 | Voquezna |
| Novo Nordisk INC | $33.97 | 2024-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.71 | 2023-2024 | Jardiance |
| Lilly USA, LLC | $32.24 | 2023-2025 | Jardiance |
| Abbott Laboratories | $19.72 | 2025 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $18.48 | 2024 | Trintellix |
| Amgen INC. | $17.99 | 2024 | Repatha, Otezla |
| Esperion Therapeutics, INC. | $15.96 | 2025 | Nexletol |
| Pfizer INC. | $15.78 | 2024 | |
| Astellas Pharma US INC | $15.33 | 2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.46 | 2023 | Xifaxan |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $11.66 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Wren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.